Madan Nishi, Sharma Satendra, Sood S K, Colah Roshan, Bhatia Late H M
Department of Pathology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi 110 095, India.
Indian J Hum Genet. 2010 Jan;16(1):16-25. doi: 10.4103/0971-6866.64941.
India is an ethnically diverse country with an approximate population of 1.2 billion. The frequency of beta-thalassemia trait (βTT) has variously been reported from <1% to 17% and an average of 3.3%. Most of these studies have been carried out on small population groups and some have been based on hospital-based patients. There is also a variation in the prevalence of hemoglobinopathies in different regions and population groups in the country. A high frequency of Hb D has been reported from the North in the Punjabi population, Hb E in the eastern region of India and Hb S is mainly reported from populations of tribal origin from different parts of the country.
To study the gene frequency of βTT and other hemoglobinopathies in three regions East (Kolkata), West (Mumbai) and North (Delhi) in larghe population group (schoolchildren) for a more accurate assessment of gene frequency for planning of control programmes for haemoglobinopathies.
This study included 5408 children from 11 schools in Delhi, 5682 from 75 schools in Mumbai and 957 schoolchildren from Kolkata who were screened for βTT and haemoglobinopathies. These included 5684 children from 75 schools in Mumbai and 5408 children from 11 schools in Delhi. Children were 11-18 years of age of both sexes. The final report is, however, only on 11090 schoolchildren from Mumbai and Delhi as data from Kolkata was restricted both in numbers and objectives and could not be included for comparison.
The overall gene frequency of βTT in Mumbai and Delhi was 4.05% being 2.68% and 5.47% in children of the two cities respectively. In Mumbai, the gene frequency was evenly distributed. Majority of the children with βTT from Mumbai were from Marathi (38.9%) and Gujarati (25%) speaking groups. Gene frequency was >5% in Bhatias, Khatris, Lohanas and Schedule Castes. In Delhi, a higher incidence was observed in schoolchildren of North and West Delhi (5.8-9.2%). The schoolchildren of North and West Delhi comprised predominantly of Punjabi origin compared to children in the South of the city (2.2%, 2.3%). When analyzed state-wise, the highest incidence was observed in children of Punjabi origin (7.6%) and was >4% from several other states. Majority of the traits from Mumbai were anemic (95.1% male and 85.6% in female). The prevalence of anemia was lower (62.7% male and 58.4% female) children with βTT from Delhi. This was a reflection of the higher prevalence of anemia in children without hemoglobinopathy in Mumbai than in Delhi. Nutritional deficiency was probably more severe and rampant in children Mumbai. Gene frequency of Hb D was greater in schoolchildren from Delhi (1.1%) than in Mumbai (0.7%). Hb S trait (0.2%) was observed exclusively in children from Mumbai. A low incidence of Hb E trait (0.04%) was seen in children in Mumbai. A higher incidence is reported from the East. The number of cases studied from the eastern region was small as the data from the East (Kolkata) could not be included in the analysis.
This study comprises a larger number of children studied for the gene frequency of βTT and other hemoglobinopathies from India. Population groups with higher gene frequencies require screening programmes and facilities for antenatal diagnosis as well as increased awareness and educational programmes to control the birth of thalassemic homozygotes. The overall carrier frequency of βTT was 4.05% and reinforces the differential frequency of β-thalassemia trait in schoolchildren from Delhi and Mumbai and the higher incidence of hemoglobin D in Punjabis as reported previously. The birth incidence calculated thereof for homozygous thalassemics would be 11,316 per year which are added each year to the existing load of homozygous thalassemics. This is much higher than the previously reported number of births annually. Hence suitable control measures need to be undertaken urgently in India.
印度是一个种族多元化的国家,人口约12亿。β地中海贫血特征(βTT)的频率报道不一,从<1%到17%不等,平均为3.3%。这些研究大多是在小群体中进行的,有些是基于医院患者。该国不同地区和人群中血红蛋白病的患病率也存在差异。据报道,在北部旁遮普人群中Hb D频率较高,在印度东部地区Hb E频率较高,而Hb S主要报道于该国不同地区的部落人群。
在大群体(学童)中研究东部(加尔各答)、西部(孟买)和北部(德里)三个地区βTT和其他血红蛋白病的基因频率,以便更准确地评估基因频率,为血红蛋白病控制项目的规划提供依据。
本研究纳入了来自德里11所学校的5408名儿童、孟买75所学校的5682名儿童以及加尔各答的957名学童,对他们进行了βTT和血红蛋白病筛查。其中包括孟买75所学校的5684名儿童和德里11所学校的5408名儿童。儿童年龄在11至18岁之间,男女皆有。然而,最终报告仅涉及来自孟买和德里的11090名学童,因为来自加尔各答的数据在数量和目标上都有限,无法纳入比较。
孟买和德里βTT的总体基因频率为4.0%,两个城市儿童中分别为2.68%和5.47%。在孟买,基因频率分布均匀。孟买大多数βTT儿童来自说马拉地语(38.�%)和古吉拉特语(25%)的群体。在巴蒂亚人、卡特里人、洛哈纳人和在册种姓中,基因频率>5%。在德里,德里北部和西部的学童中发病率较高(5.8 - 9.2%)。与该市南部的儿童(2.2%,2.3%)相比,德里北部和西部的学童主要为旁遮普血统。按邦分析时,旁遮普血统儿童的发病率最高(7.6%),其他几个邦也>4%。孟买大多数携带该特征的儿童贫血(男性95.1%,女性85.6%)。德里βTT儿童贫血的患病率较低(男性62.7%,女性58.4%)。这反映出孟买无血红蛋白病儿童的贫血患病率高于德里。孟买儿童的营养缺乏可能更严重且更普遍。德里学童中Hb D的基因频率(1.1%)高于孟买(0.7%)。Hb S特征(0.2%)仅在孟买儿童中观察到。孟买儿童中Hb E特征的发病率较低(0.04%)。据报道东部地区发病率较高。由于来自东部(加尔各答)的数据无法纳入分析,所以该地区研究的病例数较少。
本研究纳入了大量印度儿童,对βTT和其他血红蛋白病的基因频率进行了研究。基因频率较高的人群需要筛查项目和产前诊断设施,以及提高认识和开展教育项目,以控制纯合子地中海贫血患儿的出生。βTT的总体携带频率为4.05%,这进一步证实了此前报道的德里和孟买学童中β地中海贫血特征频率的差异,以及旁遮普人中血红蛋白D发病率较高的情况。据此计算出的纯合子地中海贫血患儿的出生发病率每年将为11316例,这每年都会增加到现有的纯合子地中海贫血患儿负担中。这比此前每年报道的出生病例数要高得多。因此,印度迫切需要采取适当的控制措施。